Preferred Label : pentoxifylline;
MeSH definition : A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology.
It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also
inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating
cytokine production.;
MeSH synonym : oxpentifylline;
MeSH hyponym : pentoxil; torental; agapurin; BL-191; trental; BL 191; BL191;
MeSH CAS label : 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-;
MeSH Related Number : 6493-05-6 (Pentoxifylline);
Registry Number MeSH : 6493-05-6;
Wikipedia link : https://en.wikipedia.org/wiki/Pentoxifylline;
Codes EINECS : 229-374-5;
Is substance : O;
UNII : SD6QCT3TSU;
InChIKey : BYPFEZZEUUWMEJ-UHFFFAOYSA-N;
Origin ID : D010431;
UMLS CUI : C0030899;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology.
It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also
inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating
cytokine production.
http://www.cochrane.org/fr/CD007677
2021
false
United Kingdom
France
French
meta-analysis
endometriosis
treatment outcome
pentoxifylline
anti-inflammatory agents, non-steroidal
french abstract
---
https://www.cochrane.org/fr/CD005262/PVD_dans-quelle-mesure-la-pentoxifylline-traite-t-elle-la-claudication-intermittente
2020
false
United Kingdom
France
French
meta-analysis
treatment outcome
pentoxifylline
vasodilator agents
intermittent claudication
french abstract
---
http://www.cochrane.org/fr/CD006800
2013
false
false
false
United Kingdom
France
treatment outcome
meta-analysis
french abstract
pentoxifylline
diabetic nephropathies
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66858302
2012
France
summary of product characteristics
package leaflet
tablets
pentoxifylline
---
http://www.cochrane.org/fr/CD001733
2012
United Kingdom
France
French
meta-analysis
leg ulcer
pentoxifylline
treatment outcome
vasodilator agents
french abstract
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65795354
2012
France
summary of product characteristics
package leaflet
tablets
pentoxifylline
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66514326
2012
France
summary of product characteristics
package leaflet
tablets
pentoxifylline
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60620372
2012
France
summary of product characteristics
package leaflet
pentoxifylline
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62431954
2012
France
summary of product characteristics
package leaflet
pentoxifylline
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61479280
2012
France
summary of product characteristics
package leaflet
pentoxifylline
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65599932
2012
France
summary of product characteristics
package leaflet
pentoxifylline
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69579578
2012
France
summary of product characteristics
package leaflet
tablets
pentoxifylline
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68156358
2012
France
summary of product characteristics
package leaflet
tablets
pentoxifylline
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66315349
2012
France
summary of product characteristics
package leaflet
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/jcms/c_1146460/torental
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-12/torental_02-11-2011_avis_ct11353.pdf
2011
France
French
evaluation of the transparency committee
pentoxifylline
Delayed-Action preparations
administration, oral
treatment outcome
pentoxifylline
vasodilator agents
intermittent claudication
cognition disorders
arterial occlusive diseases
insurance, health, reimbursement
---
http://www.has-sante.fr/portail/jcms/c_1146444/pentoxifylline-ratiopharm
http://www.has-sante.fr/portail/jcms/c_1146466/pentoxifylline-biogaran
http://www.has-sante.fr/portail/jcms/c_1146472/pentoxifylline-teva
http://www.has-sante.fr/portail/jcms/c_1146481/pentoxifylline-eg
http://www.has-sante.fr/portail/display.jsp?id=c_451537
http://www.has-sante.fr/portail/jcms/c_1146512/pentoflux
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-12/pentoflux_02-11-2011_avis_ct11295.pdf
http://www.has-sante.fr/portail/jcms/c_1146487/pentoxifylline-mylan
http://www.has-sante.fr/portail/jcms/c_1146502/pentoxifylline-qualimed
http://www.has-sante.fr/portail/jcms/c_1146540/pentoxifylline-sandoz
http://www.has-sante.fr/portail/jcms/c_1146550/pentoxifylline-rpg
2011
France
French
Delayed-Action preparations
administration, oral
pentoxifylline
pentoxifylline
vasodilator agents
cognition disorders
intermittent claudication
treatment outcome
arterial occlusive diseases
lower extremity
adult
aged
chronic disease
insurance, health, reimbursement
drugs, generic
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD000162
2009
false
true
false
United Kingdom
France
xanthines
pentifylline
theobromine
treatment outcome
review of literature
french abstract
propentofylline
pentoxifylline
stroke
---
http://www.has-sante.fr/portail/display.jsp?id=c_866801
2009
France
evaluation of the transparency committee
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_618032
2007
France
evaluation of the transparency committee
tablets
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_451762
2006
France
French
pentoxifylline
vasodilator agents
Delayed-Action preparations
tablets
injections
pentoxifylline
intermittent claudication
cognition disorders
aged
treatment outcome
arterial occlusive diseases
chronic disease
administration, oral
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_451570
2006
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_451577
2006
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_451562
2006
France
evaluation of the transparency committee
tablets
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_451566
2006
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_451558
2006
France
evaluation of the transparency committee
tablets
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_451554
2006
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_451541
2006
France
evaluation of the transparency committee
tablets
pentoxifylline
aged
---
http://www.has-sante.fr/portail/display.jsp?id=c_451546
2006
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_451550
2006
France
evaluation of the transparency committee
tablets
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_400102
2004
France
evaluation of the transparency committee
tablets
pentoxifylline
---
http://www.has-sante.fr/portail/display.jsp?id=c_399700
2002
France
evaluation of the transparency committee
pentoxifylline
tablets
---
http://www.has-sante.fr/portail/display.jsp?id=c_399279
2002
France
evaluation of the transparency committee
tablets
pentoxifylline
---